ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು & ಪ್ರತಿಕ್ರಿಯೆಗಳು
- ಮಾಧ್ಯಮ
@eyeonfda ತಡೆಹಿಡಿಯಲಾಗಿದೆ
ನೀವು ಖಚಿತವಾಗಿಯೂ ಈ ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡಲು ಬಯಸುವಿರಾ? ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡುವುದು @eyeonfda ಅವರನ್ನು ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ.
-
In move w/
@US_FDA implications, Prez signs exec order requiring elimination of 2 regulations for every new onehttp://politi.co/2juZQhY -
That cancelled climate and health meeting? It's back on, just not at CDC https://www.climaterealityproject.org/health
-
Comparison of
#FDA press releases 2016 to 2015 - http://ow.ly/o5a3308nWx6 -
#NIH - Study finds premature death rates diverge in the United States by race and ethnicityhttp://ow.ly/I9NO308ni4M -
#HHS nominee Price weighs in on telemedicine, innovation, and regulation in finance hearinghttp://ow.ly/sysP308nf47 -
#NEJM Perspective - Red-State Medicaid Expansions — Achilles’ Heel of#ACA Repeal?http://ow.ly/NzzJ308nehy -
#NEJM Perspective - A View from the Front Line — Physicians’ Perspectives on#ACA Repealhttp://ow.ly/m2op308ne8x -
#NIH - The Cancer Genome Atlas Research Network identifies genomic features of cervical cancerhttp://ow.ly/4Kq5308j3B4 -
eyeonfda ಹಿಂಬಾಲಿಸಿದ್ದಾರೆ Roche, Roche Diagnostics US, GSK Asia and 5 others
-
-
@RocheDiaUSA
Doing now what patients need next. Terms of Use: https://usdiagnostics.roche.com/en/Terms_and_Conditions.html …
-
-
#FDA draft guidance- Prohibition of Distributing Free Samples of Tobacco Products http://ow.ly/18Fx30854CM -
#FDA guidance - Assessment of Abuse Potential of Drugs http://ow.ly/nuXy30854rb -
#FDA draft guidance - Considerations in Demonstrating Interchangeability With a Reference Product - http://ow.ly/U4ZN30854jR -
What would happen if insurers were allowed to sell plans across state lines?
@larry_levitt explains in@JAMAForumhttp://kaiserf.am/2iAK2gf -
#FDA guidance - Nonproprietary Naming of Biological Products http://ow.ly/tHCo307Wby6 -
#FDA draft guidance - Multiple Endpoints in Clinical Trials http://ow.ly/zTIe307Wbkb -
#FDA guidance - Emergency Use Authorization of Medical Products and Related Authorities http://ow.ly/xWaJ307Wb9t -
#FDA issues draft guidance - 180-Day Exclusivity: Questions and Answers - http://ow.ly/HBeO307WaXZ -
As
#JPM17 continues,@eyeonfda looks at what's in store at#FDA, via@Fleishman http://bit.ly/2j8jTq4 -
#FDA#CDER Guidance Agenda on New & Revised Draft Guidances CDER is Planning to Publish During 2017- http://ow.ly/cqzm307Uhfz -
#FDA#AdComm to discuss potential risks of misuse of peroxide-based contact lens products http://ow.ly/rvaC307TLLO
Jonathan Rockoff
Kim Painter
eyeonfda
Kaiser Family Found
a_silverstein
ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.
Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.